Eurofins-Cerep SA (ALECR) - Total Assets
Based on the latest financial reports, Eurofins-Cerep SA (ALECR) holds total assets worth €88.84 Million EUR (≈ $103.86 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Eurofins-Cerep SA - Total Assets Trend (2000–2025)
This chart illustrates how Eurofins-Cerep SA's total assets have evolved over time, based on quarterly financial data. Also see ALECR stock market capitalisation for the company's overall valuation and market capitalisation.
Eurofins-Cerep SA - Asset Composition Analysis
Current Asset Composition (December 2025)
Eurofins-Cerep SA's total assets of €88.84 Million consist of 89.4% current assets and 10.6% non-current assets. Review ALECR liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 10.3% |
| Accounts Receivable | €55.28 Million | 62.2% |
| Inventory | €2.54 Million | 2.9% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €77.35K | 0.1% |
| Goodwill | €2.23 Million | 2.5% |
Asset Composition Trend (2000–2025)
This chart illustrates how Eurofins-Cerep SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Eurofins-Cerep SA (ALECR) stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Eurofins-Cerep SA's current assets represent 89.4% of total assets in 2025, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 10.3% of total assets in 2025, up from 8.1% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is accounts receivable at 62.2% of total assets.
Eurofins-Cerep SA Competitors by Total Assets
Key competitors of Eurofins-Cerep SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
LONZA GROUP UNSP.ADR 1/10
F:LO3A
|
Germany | €17.91 Billion |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
|
Gencurix Inc
KQ:229000
|
Korea | ₩31.17 Billion |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$16.78 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$512.35 Million |
|
Cryosite Ltd
AU:CTE
|
Australia | AU$26.55 Million |
Eurofins-Cerep SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.83 | 6.94 | 4.47 |
| Quick Ratio | 7.58 | 6.62 | 4.25 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €69.27 Million | €62.18 Million | €29.19 Million |
Eurofins-Cerep SA - Advanced Valuation Insights
This section examines the relationship between Eurofins-Cerep SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.20 |
| Latest Market Cap to Assets Ratio | 0.93 |
| Asset Growth Rate (YoY) | 5.7% |
| Total Assets | €88.84 Million |
| Market Capitalization | $82.22 Million USD |
Valuation Analysis
Near Book Valuation: The market values Eurofins-Cerep SA's assets close to their book value (0.93x), suggesting investors view the company's assets at approximately fair value.
Positive Asset Growth: Eurofins-Cerep SA's assets grew by 5.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Eurofins-Cerep SA (2000–2025)
The table below shows the annual total assets of Eurofins-Cerep SA from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €88.84 Million ≈ $103.86 Million |
+5.68% |
| 2024-12-31 | €84.06 Million ≈ $98.28 Million |
+6.07% |
| 2023-12-31 | €79.25 Million ≈ $92.65 Million |
+11.54% |
| 2022-12-31 | €71.05 Million ≈ $83.06 Million |
+18.95% |
| 2021-12-31 | €59.73 Million ≈ $69.83 Million |
+29.67% |
| 2020-12-31 | €46.06 Million ≈ $53.85 Million |
+15.30% |
| 2019-12-31 | €39.95 Million ≈ $46.71 Million |
+13.31% |
| 2018-12-31 | €35.26 Million ≈ $41.22 Million |
+16.83% |
| 2017-12-31 | €30.18 Million ≈ $35.28 Million |
+16.33% |
| 2016-12-31 | €25.94 Million ≈ $30.33 Million |
+3.02% |
| 2015-12-31 | €25.18 Million ≈ $29.44 Million |
+9.97% |
| 2014-12-31 | €22.90 Million ≈ $26.77 Million |
-17.89% |
| 2013-12-31 | €27.89 Million ≈ $32.60 Million |
-7.92% |
| 2012-12-31 | €30.28 Million ≈ $35.40 Million |
-7.45% |
| 2011-12-31 | €32.72 Million ≈ $38.26 Million |
-8.84% |
| 2010-12-31 | €35.90 Million ≈ $41.97 Million |
-18.98% |
| 2009-12-31 | €44.31 Million ≈ $51.80 Million |
-19.30% |
| 2008-12-31 | €54.91 Million ≈ $64.19 Million |
-12.47% |
| 2007-12-31 | €62.73 Million ≈ $73.34 Million |
-17.86% |
| 2006-12-31 | €76.37 Million ≈ $89.29 Million |
-8.70% |
| 2005-12-31 | €83.65 Million ≈ $97.79 Million |
+30.95% |
| 2004-12-31 | €63.87 Million ≈ $74.68 Million |
+24.65% |
| 2003-12-31 | €51.24 Million ≈ $59.91 Million |
+7.39% |
| 2002-12-31 | €47.72 Million ≈ $55.78 Million |
+16.67% |
| 2001-12-31 | €40.90 Million ≈ $47.81 Million |
+72.80% |
| 2000-12-31 | €23.67 Million ≈ $27.67 Million |
-- |
About Eurofins-Cerep SA
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company also provides research services, including compound management, and high-throughout screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was foun… Read more